{"product_id":"renal-biomarkers-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","title":"Renal Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028","description":"\u003cp\u003eRenal Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028\u003cbr\u003e\nThe global renal biomarkers market size reached US$ 1.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.0 Billion by 2028, exhibiting a growth rate (CAGR) of 7.8% during 2023-2028.\u003c\/p\u003e\n\n\u003cp\u003eRenal biomarkers are cells, proteins, lipids, microRNAs, genes, metabolites, or proteomic patterns present on a urinalysis. They assist in determining the glomerular filtration rate (GFR) of kidneys to analyze their proper functioning and evaluating pathogenic processes or pharmacological responses to therapeutic interventions. As they also aid in predicting disease progression and computing drug dosage, renal biomarkers find extensive applications in hospitals and diagnostic laboratories across the globe.\u003c\/p\u003e\n\n\u003cp\u003eRenal Biomarkers Market Trends:\u003c\/p\u003e\n\n\u003cp\u003eChronic kidney disease (CKD), non-communicable disease with considerable morbidity and mortality, has gradually become a public health concern globally and its main risk factors are diabetes, hypertension and heart diseases. The increasing number of individuals with CKD represents one of the key factors propelling the growth of the market. Moreover, renal biomarkers, including blood urea nitrogen (BUN), serum creatinine (SCr), urinary albumin\/protein and volume excretion, are used in the diagnosis of chronic kidney disease (CKD) and monitoring of the disease. Besides this, there is a growing interest of industry investors in novel single biomarkers and process-specific biomarker panels in human renal diseases around the world. These novel biomarkers provide vital diagnostic and prognostic information and help predict response to the treatment of glomerulopathies, acute kidney injury (AKI), and autosomal dominant polycystic kidney disease (ADPKD). Apart from this, renal biomarkers are becoming accessible and feasible in all-sized laboratories. This, along with the development and integration of genomics, epigenetics, transcriptomics, proteomics, and metabolomics, is positively influencing the market. Some of the other factors, such as the burgeoning healthcare industry, the rising geriatric population, and the increasing number of clinical trials for CKD worldwide, are anticipated to facilitate the growth of the market.\u003c\/p\u003e\n\n\u003cp\u003eKey Market Segmentation:\u003c\/p\u003e\n\n\u003cp\u003eIMARC Group provides an analysis of the key trends in each sub-segment of the global renal biomarkers market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on biomarker type, diagnostic technique and end user.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Biomarker Type:\u003c\/p\u003e\n\n\u003cp\u003eFunctional Biomarker\u003c\/p\u003e\n\n\u003cp\u003eSerum Creatinine\u003c\/p\u003e\n\n\u003cp\u003eSerum Cystatin C\u003c\/p\u003e\n\n\u003cp\u003eUrine Albumin\u003c\/p\u003e\n\n\u003cp\u003eUp-regulated Protein\u003c\/p\u003e\n\n\u003cp\u003eNeutrophil Gelatinase-Associated Lipocalin (NGAL)\u003c\/p\u003e\n\n\u003cp\u003eKidney Injury Molecule-1\u003c\/p\u003e\n\n\u003cp\u003eINTERLEUKIN-18\u003c\/p\u003e\n\n\u003cp\u003eOthers\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Diagnostic Technique:\u003c\/p\u003e\n\n\u003cp\u003eEnzyme-linked Immunosorbent Assay (ELISA)\u003c\/p\u003e\n\n\u003cp\u003eParticle-enhanced Turbidimetric Immunoassay (PETIA)\u003c\/p\u003e\n\n\u003cp\u003eColorimetric Assay\u003c\/p\u003e\n\n\u003cp\u003eChemiluminescent Enzyme Immunoassay (CLIA)\u003c\/p\u003e\n\n\u003cp\u003eLiquid Chromatography Mass Spectrometry (LC-MS)\u003c\/p\u003e\n\n\u003cp\u003eBreakup by End User:\u003c\/p\u003e\n\n\u003cp\u003eHospital\u003c\/p\u003e\n\n\u003cp\u003eDiagnostic Laboratory\u003c\/p\u003e\n\n\u003cp\u003eOthers\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Region:\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003c\/p\u003e\n\n\u003cp\u003eUnited States\u003c\/p\u003e\n\n\u003cp\u003eCanada\u003c\/p\u003e\n\n\u003cp\u003eAsia-Pacific\u003c\/p\u003e\n\n\u003cp\u003eChina\u003c\/p\u003e\n\n\u003cp\u003eJapan\u003c\/p\u003e\n\n\u003cp\u003eIndia\u003c\/p\u003e\n\n\u003cp\u003eSouth Korea\u003c\/p\u003e\n\n\u003cp\u003eAustralia\u003c\/p\u003e\n\n\u003cp\u003eIndonesia\u003c\/p\u003e\n\n\u003cp\u003eOthers\u003c\/p\u003e\n\n\u003cp\u003eEurope\u003c\/p\u003e\n\n\u003cp\u003eGermany\u003c\/p\u003e\n\n\u003cp\u003eFrance\u003c\/p\u003e\n\n\u003cp\u003eUnited Kingdom\u003c\/p\u003e\n\n\u003cp\u003eItaly\u003c\/p\u003e\n\n\u003cp\u003eSpain\u003c\/p\u003e\n\n\u003cp\u003eRussia\u003c\/p\u003e\n\n\u003cp\u003eOthers\u003c\/p\u003e\n\n\u003cp\u003eLatin America\u003c\/p\u003e\n\n\u003cp\u003eBrazil\u003c\/p\u003e\n\n\u003cp\u003eMexico\u003c\/p\u003e\n\n\u003cp\u003eOthers\u003c\/p\u003e\n\n\u003cp\u003eMiddle East and Africa\u003c\/p\u003e\n\n\u003cp\u003eCompetitive Landscape:\u003c\/p\u003e\n\n\u003cp\u003eThe competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Beckman Coulter Inc. (Danaher Corporation), bioMérieux SA, BioPorto A\/S, Bio-Rad Laboratories Inc., Enzo Biochem Inc., F. Hoffmann-La Roche AG, PerkinElmer Inc., Randox Laboratories Ltd., Siemens AG and Thermo Fisher Scientific Inc.\u003c\/p\u003e\n\n\u003cp\u003eKey Questions Answered in This Report\u003c\/p\u003e\n\n\u003cp\u003e1. What was the size of the global renal biomarkers market in 2022?\u003c\/p\u003e\n\n\u003cp\u003e2. What is the expected growth rate of the global renal biomarkers market during 2023-2028?\u003c\/p\u003e\n\n\u003cp\u003e3. What has been the impact of COVID-19 on the global renal biomarkers market?\u003c\/p\u003e\n\n\u003cp\u003e4. What are the key factors driving the global renal biomarkers market?\u003c\/p\u003e\n\n\u003cp\u003e5. What is the breakup of the global renal biomarkers market based on the biomarker type?\u003c\/p\u003e\n\n\u003cp\u003e6. What is the breakup of the global renal biomarkers market based on the diagnostic technique?\u003c\/p\u003e\n\n\u003cp\u003e7. What is the breakup of the global renal biomarkers market based on end user?\u003c\/p\u003e\n\n\u003cp\u003e8. What are the key regions in the global renal biomarkers market?\u003c\/p\u003e\n\n\u003cp\u003e9. Who are the key players\/companies in the global renal biomarkers market?\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"May, 2023 \/ 144 Pages \/ MCW16230218","offer_id":47647058133298,"sku":null,"price":2999.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/renal-biomarkers-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}